Facility Is Also Producing Smart Packaged MABR Units to Meet China & Future Global DemandMelbourne, Sep 28, 2017 AEST (ABN Newswire) - Fluence Corporation Limited (ASX:FLC) (OTCMKTS:EMFGF) ("Fluence" or the "Company"), a global leader in water and wastewater treatment solutions, today announced that it has successfully produced the first Membrane Aerated Biofilm Reactor (MABR) module in its newly-built production facility in Changzhou, Jiangsu Province, China.
The spiral production line was developed and tested in Israel with all required machinery and equipment shipped and successfully installed in the Changzhou facility. The plant is now fully operational and ready for the mass production of MABR modules.
In addition, part of the production at the plant is exclusively dedicated to the assembly of MABR modules in containerized form to deliver Containerized Smart Packaged MABR (CMABR) units. CMABR being containerized enables a faster path to plant commissioning and thereby revenue recognition. The Company expects to ship these Smart Packaged MABR units to meet growing rural wastewater treatment demand in China, and other markets across the globe.
The first spirals and the first MABR module (comprising 2 spirals) from the plant have been produced. The Company intends to ramp production capacity in the coming months to meet growing market demand in China. The planned capacity of the first production line is 7,500 MABR modules annually, which corresponds to approximately US$75 million (A$100 million) in potential annual sales.
A second production line can be added if required and at low capital expenditure cost, to increase throughput to meet growing demand.
The first CMABR unit is in production, consisting of 3 MABR modules. (see link below)
The Changzhou facility has the planned capacity to produce up to 2,500 CMABR units each year. To ensure the high quality of each MABR module and CMABR unit produced, a sophisticated semi-automated test station is now operating to test each unit as it is manufactured at the Changzhou plant.
Henry Charrabé, CEO of Fluence, commented, "Successfully producing the first MABR module in our Changzhou factory marks another key milestone for us. As anticipated, we remain on track to supply cost-optimized MABR & CMABR products for future demand both to the China market and globally. We believe the ability to meet demand through local production gives Fluence a significant competitive edge over our peers, because it keeps our costs down and allows us to fulfill orders rapidly. We look forward to ramping our production to further meet growing market demand."
To view figures, please visit:
About Fluence Corporation Ltd
Fluence Corporation’s (ASX:FLC) (OTCMKTS:EMFGF) vision is to become a leading global provider of fast-to-deploy decentralized and packaged water and wastewater treatment solutions, a market estimated to grow to US$22B by 2021*. Fluence has experience operating in over 70 countries worldwide and employs more than 300 highly trained water professionals around the globe. The Company provides local, sustainable treatment and reuse solutions while empowering businesses and communities worldwide to make the most of their water resources.
Fluence offers an integrated range of services across the complete water cycle, from early stage evaluation, through design and delivery to ongoing support and optimization of water related assets. With core operations in North America, South America, the Middle East and Europe, one of Fluence’s main focuses will be expanding into the vast market in China for rural wastewater treatment.
* Sources: MarketandMarkets Analysis, Global Water Intelligence, company estimates
For more information please visit our website: http://www.fluencecorp.com
Fluence Corporation Ltd